Our data indicated that LINC01589 along with clinical stages, histologic grade, residual tumor, percentage of tumor invasion primary therapy outcomes, histological types, radiation therapy, and patients age as well as TP53 status were determining factors in the prognosis of UCEC patients. This evidence concerns the gene TP53 and neoplasm.